Wang C.-C.Chen J.-H.Yu W.-C.Cheng J.-J.Yin W.-H.CHAU-CHUNG WULi A.-H.Lin W.-S.Chen P.-S.Ueng K.-C.Huang J.-L.Tsai F.-C.Wang C.-H.Fu T.-C.Liu M.-H.PEY-RONG CHENPai H.-Y.Cherng W.-J.2020-11-122020-11-1220121011-6842https://www.scopus.com/inward/record.uri?eid=2-s2.0-84865461179&partnerID=40&md5=1af6d9e6ebb96c82783dc3195268302dhttps://scholars.lib.ntu.edu.tw/handle/123456789/520844[SDGs]SDG3aldosterone antagonist; amino terminal pro brain natriuretic peptide; brain natriuretic peptide; bumetanide; candesartan; captopril; chlorothiazide; creatinine; electrolyte; enalapril; eplerenone; fosinopril; glucose; hydrochlorothiazide; lisinopril; losartan; quinapril; ramipril; spironolactone; torasemide; valsartan; angiocardiography; ascites; blood cell count; cardiopulmonary exercise test; cardiovascular magnetic resonance; central venous pressure; Chinese; computer assisted tomography; creatinine blood level; disease severity; diuretic therapy; dyspnea; electrocardiography; electrolyte blood level; exercise tolerance; fatigue; fluid retention; glomerulus filtration rate; glucose blood level; heart catheterization; heart failure; heart left ventricle filling; heart left ventricle filling pressure; heart muscle biopsy; hepatomegaly; Holter monitoring; human; ischemic heart disease; liver function test; lung function test; peripheral edema; practice guideline; prognosis; radioisotope ventriculography; review; stress echocardiography; symptomatology; tachycardia; Taiwan; thorax radiography; transesophageal echocardiography; urinalysisreview2-s2.0-84865461179